P Buchwald
P Buchwald
Director, Drug Discovery, Diabetes Research Institute, University of Miami, FL
Verified email at med.miami.edu
Title
Cited by
Cited by
Year
Soft drug design: general principles and recent applications
N Bodor, P Buchwald
Medicinal research reviews 20 (1), 58-101, 2000
2652000
Octanol-water partition: searching for predictive models
P Buchwald, N Bodor
Current medicinal chemistry 5 (5), 353-380, 1998
2051998
Recent advances in the brain targeting of neuropharmaceuticals by chemical delivery systems
N Bodor, P Buchwald
Advanced drug delivery reviews 36 (2-3), 229-254, 1999
1911999
Oscillatory dynamics of Cdc42 GTPase in the control of polarized growth
M Das, T Drake, DJ Wiley, P Buchwald, D Vavylonis, F Verde
Science 337 (6091), 239-243, 2012
1382012
Characterization of twenty-five ovarian tumour cell lines that phenocopy primary tumours
TA Ince, AD Sousa, MA Jones, JC Harrell, ES Agoston, M Krohn, ...
Nature communications 6 (1), 1-14, 2015
1352015
Introduction: Toward a critique of posthuman futures
B Simon
Cultural Critique, 1-9, 2003
121*2003
Molecular size based approach to estimate partition properties for organic solutes
N Bodor, P Buchwald
The Journal of Physical Chemistry B 101 (17), 3404-3412, 1997
1201997
FEM-based oxygen consumption and cell viability models for avascular pancreatic islets
P Buchwald
Theoretical Biology and Medical Modelling 6 (1), 5, 2009
1182009
FEM-based oxygen consumption and cell viability models for avascular pancreatic islets
P Buchwald
Theoretical Biology and Medical Modelling 6 (1), 5, 2009
1182009
Small‐molecule protein–protein interaction inhibitors: Therapeutic potential in light of molecular size, chemical space, and ligand binding efficiency considerations
P Buchwald
IUBMB life 62 (10), 724-731, 2010
992010
Barriers to remember: brain-targeting chemical delivery systems and Alzheimer's disease
N Bodor, P Buchwald
Drug discovery today 7 (14), 766-774, 2002
952002
A local glucose-and oxygen concentration-based insulin secretion model for pancreatic islets
P Buchwald
Theoretical biology and medical modelling 8 (1), 1-25, 2011
942011
Ophthalmic drug design based on the metabolic activity of the eye: soft drugs and chemical delivery systems
N Bodor, P Buchwald
The AAPS journal 7 (4), E820-E833, 2005
932005
Drug targeting via retrometabolic approaches
N Bodor, P Buchwald
Pharmacology & therapeutics 76 (1-3), 1-27, 1997
841997
Quantitative structure− metabolism relationships: Steric and nonsteric effects in the enzymatic hydrolysis of noncongener carboxylic esters
P Buchwald, N Bodor
Journal of medicinal chemistry 42 (25), 5160-5168, 1999
761999
Direct, differential‐equation‐based in‐vitro–in‐vivo correlation (IVIVC) method
P Buchwald
Journal of pharmacy and pharmacology 55 (4), 495-504, 2003
742003
A simple, predictive, structure‐based skin permeability model
P Buchwald, N Bodor
Journal of Pharmacy and Pharmacology 53 (8), 1087-1098, 2001
722001
Octanol–water partition of nonzwitterionic peptides: Predictive power of a molecular size‐based model
P Buchwald, N Bodor
Proteins: Structure, Function, and Bioinformatics 30 (1), 86-99, 1998
681998
Brain-targeted drug delivery
N Bodor, P Buchwald
American Journal of Drug Delivery 1 (1), 13-26, 2003
672003
Computer-aided drug design: the role of quantitative structure–property, structure–activity and structure–metabolism relationships (QSPR, QSAR, QSMR)
P Buchwald, N Bodor
Drugs Future 27 (6), 577-588, 2002
672002
The system can't perform the operation now. Try again later.
Articles 1–20